Stock 2137 BRII BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Brii Biosciences Limited

Equities

2137

KYG1645A1094

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:13 2024-04-23 am EDT 		5-day change 1st Jan Change
0.98 HKD -2.97% Intraday chart for Brii Biosciences Limited +11.36% -57.02%
Mar. 25 Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024
Mar. 22 Brii Biosciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Brii Biosciences Ltd is a biotechnology company based in China and the United States principally engaged in developing therapies for infectious diseases. The Company's products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens. The Company is also developing therapies for COVID-19 and other diseases.

Number of employees: 128

Sales per Business

HKD in Million2021Weight2022Weight Delta
Therapies for Infectious Diseases and Central Nervous System Diseases
100.0 %
0 nan % 60 100.0 % -

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
0 nan % 60 100.0 % -

Managers

Managers TitleAgeSince
Zhi Hong CEO
 Chief Executive Officer 60 17-12-07
An Kang Li DFI
 Director of Finance/CFO 47 20-08-31
David Margolis CTO
 Chief Tech/Sci/R&D Officer - -
Yao Zhang CTO
 Chief Tech/Sci/R&D Officer - -
Qing Zhu CTO
 Chief Tech/Sci/R&D Officer 57 18-04-01
Eleanor de Groot CTO
 Chief Tech/Sci/R&D Officer 55 22-08-14
Chris Fang IRC
 Investor Relations Contact - -
Karen D. Neuendorff HRO
 Human Resources Officer 49 22-01-26
Lisa Trivison Beck PRN
 Corporate Officer/Principal 62 18-03-11
Jean-Luc Samuel Francois Girardet PRN
 Corporate Officer/Principal 57 18-03-18

Members of the board

Members of the board TitleAgeSince
Gregg Alton BRD
 Director/Board Member 58 21-06-21
Tai Yin Yang BRD
 Director/Board Member 70 22-08-31
Robert Nelsen BRD
 Director/Board Member 60 18-06-21
Martin Murphy BRD
 Director/Board Member 81 21-06-21
Yiu Wa Tsui BRD
 Director/Board Member 74 21-06-21
Zhi Hong CEO
 Chief Executive Officer 60 17-12-07
Hui Tang BRD
 Director/Board Member 64 21-06-21
An Kang Li DFI
 Director of Finance/CFO 47 20-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 729,639,166 587,398,431 ( 80.51 %) 0 80.51 %

Shareholders

NameEquities%Valuation
Boyu Capital Advisory Co. Ltd.
9.871 %
72,019,612 9.871 % 8 M $
Shanghai Yunfeng Investment Management Co. Ltd.
4.943 %
36,069,510 4.943 % 4 M $
Hongshan
4.772 %
34,818,757 4.772 % 4 M $
Invesco Advisers, Inc.
4.626 %
33,751,238 4.626 % 4 M $
Zhi Hong
4.441 %
32,400,000 4.441 % 4 M $
Bosera Asset Management Co., Ltd.
0.7769 %
5,668,500 0.7769 % 659 076 $
UBS Asset Management (Hong Kong) Ltd.
0.6220 %
4,538,000 0.6220 % 527 633 $
An Kang Li
0.1261 %
920,082 0.1261 % 106 978 $
Xinyuan Asset Management Co., Ltd.
0.0956 %
697,500 0.0956 % 81 098 $
Hwabao WP Fund Management Co., Ltd.
0.008497 %
62,000 0.008497 % 7 209 $

Company contact information

Brii Biosciences Ltd. (China)

Zhongguancun Dongsheng, Building 7 1 North Yongtaizhuang Road

100192, Haidian

+

http://www.briibio.com
address Brii Biosciences Limited(2137)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Ratings for Brii Biosciences Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.9337 CNY
Average target price
4.303 CNY
Spread / Average Target
+360.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
BRII BIOSCIENCES LIMITED Stock Brii Biosciences Limited
-57.02% 94.04M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.71% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.49% 96.73B
ARGENX SE Stock argenx SE
+0.96% 21.31B
BIONTECH SE Stock BioNTech SE
-16.61% 21.21B
GENMAB A/S Stock Genmab A/S
-6.73% 18.79B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.14% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-27.40% 13.68B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+1.44% 13.44B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+21.29% 10.98B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2137 Stock
  4. Company Brii Biosciences Limited